Jeff Cappuccio

Vice President of Sales and Marketing at Precigen

Speaker

Jeff Cappuccio is Vice President of Sales and Marketing at Precigen. He is currently focused on commercializing an adenoviral vector immunotherapy for a rare disease known as recurrent respiratory papillomatosis (RRP). His 28 -plus year career has spanned numerous leading pharmaceutical and start-up biotech companies including Pharmacia & Upjohn, Pfizer, Sanofi, Agennix, and Astellas. He has cross-functional, commercial leadership experience in sales, marketing, commercial development, training, leadership development, and market access in both US and global roles. While his experience covers many therapeutic areas including CNS, women’s health, and urology, he has spent the past 18 years focused in oncology across a broad array of solid and hematologic malignancies including lung cancer, prostate cancer, bladder cancer, and rare diseases such as gastric/GEJ, AML, CLL, as well as head and neck cancers. Jeff has significant launch experience with many successful brands, as well as global market development experience with dendritic cell mediated immunotherapy. Prior to joining Precigen, Jeff built multiple, award-winning sales teams to launch a $4B oncology franchise and led the market access strategic planning for new product launches and LCM of the oncology portfolio at Astellas. Jeff earned a Bachelor of Arts degree in Business Management from Gettysburg College and an MBA in Strategic Marketing from the Fox School of Business at Temple University.